Syneos Health (SYNH) sees Significant Insider Sales Extending the Trend of Last Quarter
10:19 PM EST, 02/04/2021 (MT Newswires) -- In SEC filings today Syneos Health revealed two insiders -- Paul Colvin, Officer, and Alistair MacDonald, Director and Officer -- disposed of 72,983 shares in the company having a market value of approximately $5,518,169. There have been 8 insiders with buy/sell transactions in the past 90 days prior to these filings. All of these trades have been sales resulting in the disposition of 12,473,318 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 12,546,301 shares and have averaged 1,254,630 shares per transaction over this time period.
Today's Insider Activity
Relative to its peers over the last 90 days, insider buy/sell trading at Syneos Health is above the 207-company peer group average. Biotechnology & Medical Research peer group saw 234 buy/sell trades during this period for an average of 1.1 transactions per company. The number of shares per buy/sell trade for Syneos Health insiders was also higher. Within the peer group there were 78,522,734 shares purchased and 33,032,692 shares sold with company insiders acquiring 313,724 shares on average.
The data obtained in creating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.